Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 750 of 2228 entries
View as:

Interaction of BI 691751 With Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT02044393 Org: User:
Start: 01/31/14 End: 05/31/14 Due: 05/31/15

A Study in Healthy Men to Test How BI 1291583 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT05833035 Org: User:
Start: 04/24/23 End: 07/05/23 Due: 07/05/24

Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data

Phase: N/A Priority: Normal
NCT ID: NCT05393245 Org: User:
Start: 09/30/22 End: 12/07/22 Due: 12/07/23

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04172701 Org: User:
Start: 04/15/20 End: 12/31/20 Due: 12/31/21

Investigating Idiopathic Pulmonary Fibrosis in Greece

Phase: N/A Priority: Normal
NCT ID: NCT03074149 Org: User:
Start: 04/04/17 End: 03/30/21 Due: 03/30/22

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01248364 Org: User:
Start: 11/30/10 End: 07/31/13 Due: 07/31/14

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT02235402 Org: User:
Start: 12/31/97 End: - Due: -

Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02204033 Org: User:
Start: 03/31/99 End: - Due: -

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01634113 Org: User:
Start: 07/31/12 End: 12/31/14 Due: 12/31/15

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

Phase: N/A Priority: Normal
NCT ID: NCT00274066 Org: User:
Start: 10/31/02 End: 09/30/03 Due: 09/30/04

Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL

Phase: N/A Priority: Normal
NCT ID: NCT02268136 Org: User:
Start: 04/30/99 End: - Due: -

Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02273414 Org: User:
Start: 07/31/99 End: - Due: -

Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264171 Org: User:
Start: 04/30/08 End: - Due: -

RUSSE / Russian Spiriva® Safety & Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT00613574 Org: User:
Start: - End: 10/31/07 Due: 10/31/08

Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02145741 Org: User:
Start: 06/11/14 End: 07/14/23 Due: 07/14/24

The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)

Phase: N/A Priority: Normal
NCT ID: NCT02254148 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

12 / 48 wk Pivotal PFT vs PBO in COPD II

Phase: N/A Priority: Normal
NCT ID: NCT00782509 Org: User:
Start: 02/28/09 End: - Due: -

Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02184273 Org: User:
Start: 03/31/02 End: - Due: -

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT04702893 Org: User:
Start: 05/28/21 End: 04/09/24 Due: 04/09/25

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02952248 Org: User:
Start: 11/21/16 End: 08/01/23 Due: 08/01/24

Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01922349 Org: User:
Start: 08/31/13 End: 05/31/14 Due: 05/31/15

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

Phase: N/A Priority: Normal
NCT ID: NCT06091930 Org: User:
Start: 02/16/24 End: 02/11/27 Due: 02/11/28

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06424288 Org: User:
Start: 06/17/24 End: 05/22/28 Due: 05/22/29

A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Phase: N/A Priority: Normal
NCT ID: NCT04429087 Org: User:
Start: 09/23/20 End: 12/15/25 Due: 12/15/26

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT06324357 Org: User:
Start: 06/28/24 End: 09/28/29 Due: 09/28/30